关注
Paul Engeroff
Paul Engeroff
在 dbmr.unibe.ch 的电子邮件经过验证
标题
引用次数
引用次数
年份
Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy
A Zeltins, J West, F Zabel, A El Turabi, I Balke, S Haas, M Maudrich, ...
npj Vaccines 2 (1), 30, 2017
992017
Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens
F Storni, A Zeltins, I Balke, MD Heath, MF Kramer, MA Skinner, L Zha, ...
Journal of Allergy and Clinical Immunology 145 (4), 1240-1253. e3, 2020
902020
Vaccination with nanoparticles combined with micro-adjuvants protects against cancer
MO Mohsen, MD Heath, G Cabral-Miranda, C Lipp, A Zeltins, M Sande, ...
Journal for immunotherapy of cancer 7, 1-12, 2019
662019
The role of CD23 in the regulation of allergic responses
P Engeroff, M Vogel
Allergy 76 (7), 1981-1989, 2021
602021
Allergens displayed on virus‐like particles are highly immunogenic but fail to activate human mast cells
P Engeroff, F Caviezel, F Storni, F Thoms, M Vogel, MF Bachmann
Allergy 73 (2), 341-349, 2018
572018
CD23 provides a noninflammatory pathway for IgE-allergen complexes
P Engeroff, F Caviezel, D Mueller, F Thoms, MF Bachmann, M Vogel
Journal of Allergy and Clinical immunology 145 (1), 301-311. e4, 2020
422020
Virus-like particle (VLP) plus microcrystalline tyrosine (MCT) adjuvants enhance vaccine efficacy improving T and B cell immunogenicity and protection against Plasmodium …
G Cabral-Miranda, MD Heath, MO Mohsen, AC Gomes, P Engeroff, ...
Vaccines 5 (2), 10, 2017
342017
A novel recycling mechanism of native IgE-antigen complexes in human B cells facilitates transfer of antigen to dendritic cells for antigen presentation
P Engeroff, M Fellmann, D Yerly, MF Bachmann, M Vogel
Journal of Allergy and Clinical Immunology 142 (2), 557-568. e6, 2018
302018
A single monoclonal antibody against the peanut allergen Ara h 2 protects against systemic and local peanut allergy
F Storni, G Cabral-Miranda, E Roesti, L Zha, P Engeroff, A Zeltins, ...
International archives of allergy and immunology 181 (5), 334-341, 2020
232020
Glycan-specific IgG anti-IgE autoantibodies are protective against allergic anaphylaxis in a murine model
P Engeroff, K Plattner, F Storni, F Thoms, KF Boligan, L Muerner, A Eggel, ...
Journal of Allergy and Clinical Immunology 147 (4), 1430-1441, 2021
162021
The potential of exosomes in allergy immunotherapy
P Engeroff, M Vogel
Vaccines 10 (1), 133, 2022
142022
Anakinra reduces lung inflammation in experimental acute lung injury
P Engeroff, A Belbézier, A Monsel, D Klatzmann
Immunity, Inflammation and Disease 10 (2), 123-129, 2022
72022
IgE glycans promote anti-IgE IgG autoantibodies that facilitate IgE serum clearance via Fc Receptors
K Plattner, Z Gharailoo, S Zinkhan, P Engeroff, MF Bachmann, M Vogel
Frontiers in immunology 13, 1069100, 2022
52022
The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference
P Engeroff, MF Bachmann
Expert review of vaccines 18 (1), 1-3, 2019
52019
IgE glycosylation is essential for the function of omalizumab
K Plattner, G Augusto, L Muerner, S von Gunten, L Jörg, P Engeroff, ...
Allergy 78 (9), 2546-2549, 2023
42023
Generation of a virus‐like particles based vaccine against IgE
Z Gharailoo, K Plattner, G Augusto, P Engeroff, M Vogel, MF Bachmann
Allergy, 2024
22024
Mouse IgE clone SPE-7 can contain functional mouse IgG.
M Sypka, M Zwicker, SMP Braga, AC Uldry, M Vogel, PS Engeroff
Allergy, 2024
12024
IgG in the control of FcεRI activation: a battle on multiple fronts
F Storni, M Vogel, MF Bachmann, P Engeroff
Frontiers in immunology 14, 1339171, 2024
12024
The role of IgE receptors in the control of allergic reaction
P Engeroff, M Vogel
REVUE FRANCAISE D ALLERGOLOGIE 59 (3), 204-206, 2019
12019
Development of a recombinant vaccine based on virus-like particles for the treatment of peanut allergy
F Storni, A Zeltins, MD Heath, MF Kramer, MA Skinner, L Zha, E Roesti, ...
ALLERGY 73, 102-102, 2018
12018
系统目前无法执行此操作,请稍后再试。
文章 1–20